Follow
Mitch Levesque, PhD.
Mitch Levesque, PhD.
Associate Professor, Faculty of Medicine, University of Zurich Hospital, University of Zurich
Verified email at usz.ch - Homepage
Title
Cited by
Cited by
Year
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
VS Viswanathan, MJ Ryan, HD Dhruv, S Gill, OM Eichhoff, ...
Nature 547 (7664), 453-457, 2017
8732017
The auxin influx carrier LAX3 promotes lateral root emergence
K Swarup, E Benková, R Swarup, I Casimiro, B Péret, Y Yang, G Parry, ...
Nature cell biology 10 (8), 946-954, 2008
8122008
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
M Das Thakur, F Salangsang, AS Landman, WR Sellers, NK Pryer, ...
Nature 494 (7436), 251-255, 2013
7952013
An evolutionarily conserved mechanism delimiting SHR movement defines a single layer of endodermis in plants
H Cui, MP Levesque, T Vernoux, JW Jung, AJ Paquette, KL Gallagher, ...
Science 316 (5823), 421-425, 2007
5462007
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
C Krieg, M Nowicka, S Guglietta, S Schindler, FJ Hartmann, LM Weber, ...
Nature medicine 24 (2), 144-153, 2018
5312018
Toward minimal residual disease-directed therapy in melanoma
F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ...
Cell 174 (4), 843-855. e19, 2018
4082018
Receptor-Like Kinase ACR4 Restricts Formative Cell Divisions in the Arabidopsis Root
I De Smet, V Vassileva, B De Rybel, MP Levesque, W Grunewald, ...
science 322 (5901), 594-597, 2008
3932008
Whole-Genome Analysis of the SHORT-ROOT Developmental Pathway in Arabidopsis
MP Levesque, T Vernoux, W Busch, H Cui, JY Wang, I Blilou, H Hassan, ...
PLoS biology 4 (5), e143, 2006
3682006
CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets
M Nowicka, C Krieg, LM Weber, FJ Hartmann, S Guglietta, B Becher, ...
F1000Research 6, 2017
2982017
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
D Zingg, J Debbache, SM Schaefer, E Tuncer, SC Frommel, P Cheng, ...
Nature communications 6 (1), 1-17, 2015
2922015
Bimodular auxin response controls organogenesis in Arabidopsis
I De Smet, S Lau, U Voß, S Vanneste, R Benjamins, EH Rademacher, ...
Proceedings of the National Academy of Sciences 107 (6), 2705-2710, 2010
2902010
Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy
MP Smith, H Brunton, EJ Rowling, J Ferguson, I Arozarena, Z Miskolczi, ...
Cancer cell 29 (3), 270-284, 2016
2002016
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
F Newell, Y Kong, JS Wilmott, PA Johansson, PM Ferguson, C Cui, Z Li, ...
Nature communications 10 (1), 1-15, 2019
1682019
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ...
Nature communications 8 (1), 1-13, 2017
1652017
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell CarcinomaSteroids Impair Tertiary …
K Siliņa, A Soltermann, FM Attar, R Casanova, ZM Uckeley, H Thut, ...
Cancer research 78 (5), 1308-1320, 2018
1622018
Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching
MPL Daniel S Widmer, Keith S Hoek, Phil F Cheng, Ossia
Journal of Investigative Dermatology 3, 2013
155*2013
IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
E Guenova, Y Skabytska, W Hoetzenecker, G Weindl, K Sauer, M Tham, ...
Proceedings of the National Academy of Sciences 112 (7), 2163-2168, 2015
1482015
Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism
K Grønskov, CM Dooley, E Østergaard, RN Kelsh, L Hansen, ...
The American Journal of Human Genetics 92 (3), 415-421, 2013
1222013
The mitogen-activated protein kinase pathway in melanoma part I–activation and primary resistance mechanisms to BRAF inhibition
T Amaral, T Sinnberg, F Meier, C Krepler, M Levesque, H Niessner, ...
European journal of cancer 73, 85-92, 2017
1212017
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy
A Nosrati, KK Tsai, SM Goldinger, P Tumeh, B Grimes, K Loo, AP Algazi, ...
British journal of cancer 116 (9), 1141-1147, 2017
1132017
The system can't perform the operation now. Try again later.
Articles 1–20